{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:06:25Z","timestamp":1769069185201,"version":"3.49.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":1324,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000866","name":"International AIDS Vaccine Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1074\/jbc.m116.725614","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T02:50:38Z","timestamp":1479869438000},"page":"278-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies"],"prefix":"10.1016","volume":"292","author":[{"given":"Sannula","family":"Kesavardhana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raksha","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Citron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohini","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Ecto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonavinakere Seetharam","family":"Srilatha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"DiStefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Swoyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph G.","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somnath","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia C.","family":"LaBranche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica A.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghavan","family":"Varadarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M116.725614_bib1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.chom.2012.09.008","article-title":"A blueprint for HIV vaccine discovery","volume":"12","author":"Burton","year":"2012","journal-title":"Cell Host Microbe."},{"key":"10.1074\/jbc.M116.725614_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ni.3158","article-title":"Antibody responses to envelope glycoproteins in HIV-1 infection","volume":"16","author":"Burton","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1074\/jbc.M116.725614_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature07159","article-title":"Molecular architecture of native HIV-1 gp120 trimers","volume":"455","author":"Liu","year":"2008","journal-title":"Nature."},{"key":"10.1074\/jbc.M116.725614_bib4","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.1245625","article-title":"Crystal structure of a soluble cleaved HIV-1 envelope trimer","volume":"342","author":"Julien","year":"2013","journal-title":"Science."},{"key":"10.1074\/jbc.M116.725614_bib5","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.1245627","article-title":"Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer","volume":"342","author":"Lyumkis","year":"2013","journal-title":"Science."},{"key":"10.1074\/jbc.M116.725614_bib6","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nsmb.2711","article-title":"Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy","volume":"20","author":"Bartesaghi","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1074\/jbc.M116.725614_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.sbi.2013.03.007","article-title":"HIV-1 envelope glycoprotein structure","volume":"23","author":"Merk","year":"2013","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1074\/jbc.M116.725614_bib8","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.bbapap.2014.05.010","article-title":"Immunogen design for HIV-1 and influenza","volume":"1844","author":"Rathore","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1074\/jbc.M116.725614_bib9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm.1949","article-title":"Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?","volume":"15","author":"Stamatatos","year":"2009","journal-title":"Nat. Med."},{"key":"10.1074\/jbc.M116.725614_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/imr.12075","article-title":"HIV-1 neutralizing antibodies: understanding nature's pathways","volume":"254","author":"Mascola","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1074\/jbc.M116.725614_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nri3516","article-title":"Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning","volume":"13","author":"Kwong","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1074\/jbc.M116.725614_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2014.04.008","article-title":"Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers","volume":"40","author":"Blattner","year":"2014","journal-title":"Immunity."},{"key":"10.1074\/jbc.M116.725614_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2012.10.004","article-title":"Broadly neutralizing antibodies against HIV-1: templates for a vaccine","volume":"435","author":"van Gils","year":"2013","journal-title":"Virology."},{"key":"10.1074\/jbc.M116.725614_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/science.aab1253","article-title":"HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies","volume":"349","author":"Williams","year":"2015","journal-title":"Science."},{"key":"10.1074\/jbc.M116.725614_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.20101907","article-title":"MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1","volume":"208","author":"Ruprecht","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1074\/jbc.M116.725614_bib16","doi-asserted-by":"crossref","first-page":"9590","DOI":"10.1128\/JVI.00494-14","article-title":"Stabilizing the native trimer of HIV-1 Env by destabilizing the heterodimeric interface of the gp41 postfusion six-helix bundle","volume":"88","author":"Kesavardhana","year":"2014","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib17","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/jbc.M116.725614_bib18","doi-asserted-by":"crossref","first-page":"15614","DOI":"10.1073\/pnas.1413550111","article-title":"Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development","volume":"111","author":"Lewis","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M116.725614_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/infdis\/jis367","article-title":"Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials","volume":"206","author":"Montefiori","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1074\/jbc.M116.725614_bib20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/jbc.M116.725614_bib21","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1056\/NEJMra066267","article-title":"An HIV vaccine: evolving concepts","volume":"356","author":"Johnston","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/jbc.M116.725614_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature12893","article-title":"Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV","volume":"505","author":"Roederer","year":"2014","journal-title":"Nature."},{"key":"10.1074\/jbc.M116.725614_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1126\/science.aab3886","article-title":"HIV-1 vaccines: protective efficacy of adenovirus\/protein vaccines against SIV challenges in rhesus monkeys","volume":"349","author":"Barouch","year":"2015","journal-title":"Science."},{"key":"10.1074\/jbc.M116.725614_bib24","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1128\/JVI.74.12.5716-5725.2000","article-title":"Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins","volume":"74","author":"Yang","year":"2000","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib25","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1128\/JVI.74.11.5091-5100.2000","article-title":"Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits","volume":"74","author":"Sanders","year":"2000","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1128\/JVI.74.2.627-643.2000","article-title":"A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure","volume":"74","author":"Binley","year":"2000","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1074\/jbc.M116.725614_bib28","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/JVI.76.9.4634-4642.2002","article-title":"Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin","volume":"76","author":"Yang","year":"2002","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib29","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1128\/JVI.79.15.9954-9969.2005","article-title":"Soluble mimetics of human immunodeficiency virus type 1 viral spikes produced by replacement of the native trimerization domain with a heterologous trimerization motif: characterization and ligand binding analysis","volume":"79","author":"Pancera","year":"2005","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib30","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.1074\/jbc.M114.621185","article-title":"Antigenicity and immunogenicity of a trimeric envelope protein from an Indian clade C HIV-1 isolate","volume":"290","author":"Sneha Priya","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M116.725614_bib31","doi-asserted-by":"crossref","first-page":"12111","DOI":"10.1073\/pnas.1204533109","article-title":"HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120","volume":"109","author":"Kovacs","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M116.725614_bib32","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.1128\/JVI.01247-13","article-title":"Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in non-human primates","volume":"87","author":"Chakrabarti","year":"2013","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/science.aac4223","article-title":"HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers","volume":"349","author":"Sanders","year":"2015","journal-title":"Science."},{"key":"10.1074\/jbc.M116.725614_bib34","doi-asserted-by":"crossref","first-page":"9815","DOI":"10.1074\/jbc.M112.425959","article-title":"Design of an Escherichia coli expressed HIV-1 gp120 fragment immunogen that binds to b12 and induces broad and potent neutralizing antibodies","volume":"288","author":"Bhattacharyya","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M116.725614_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature13808","article-title":"Structure and immune recognition of trimeric pre-fusion HIV-1 Env","volume":"514","author":"Pancera","year":"2014","journal-title":"Nature."},{"key":"10.1074\/jbc.M116.725614_bib36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/JVI.01645-15","article-title":"Structure\/function studies involving the V3 region of the HIV-1 envelope delineate multiple factors that affect neutralization sensitivity","volume":"90","author":"Zolla-Pazner","year":"2015","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib37","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1021\/bi300003v","article-title":"Designed cyclic permutants of HIV-1 gp120: implications for envelope trimer structure and immunogen design","volume":"51","author":"Saha","year":"2012","journal-title":"Biochemistry."},{"key":"10.1074\/jbc.M116.725614_bib38","doi-asserted-by":"crossref","first-page":"17624","DOI":"10.1073\/pnas.1415789111","article-title":"Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex","volume":"111","author":"Sok","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M116.725614_bib39","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"Zhou","year":"2010","journal-title":"Science."},{"key":"10.1074\/jbc.M116.725614_bib40","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1213256","article-title":"A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield","volume":"334","author":"Pejchal","year":"2011","journal-title":"Science."},{"key":"10.1074\/jbc.M116.725614_bib41","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature."},{"key":"10.1074\/jbc.M116.725614_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/JVI.01791-15","article-title":"New member of the V1V2-directed CAP256-VRC26 lineage that shows increased breadth and exceptional potency","volume":"90","author":"Doria-Rose","year":"2015","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002797","article-title":"Structural mechanism of trimeric HIV-1 envelope glycoprotein activation","volume":"8","author":"Tran","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1074\/jbc.M116.725614_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004767","article-title":"Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer","volume":"11","author":"Derking","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1074\/jbc.M116.725614_bib45","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1128\/JVI.79.3.1713-1723.2005","article-title":"Characterization of gp120 and its single-chain derivatives, gp120-CD4D12 and gp120-M9: implications for targeting the CD4i epitope in human immunodeficiency virus vaccine design","volume":"79","author":"Varadarajan","year":"2005","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib46","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1128\/JVI.02853-13","article-title":"Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"88","author":"deCamp","year":"2014","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib47","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/JVI.01992-08","article-title":"Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals","volume":"83","author":"Li","year":"2009","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib48","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/JVI.06973-11","article-title":"PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4","volume":"86","author":"Falkowska","year":"2012","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib49","doi-asserted-by":"crossref","first-page":"27100","DOI":"10.1074\/jbc.M110.152272","article-title":"Design of a non-glycosylated outer domain-derived HIV-1 gp120 immunogen that binds to CD4 and induces neutralizing antibodies","volume":"285","author":"Bhattacharyya","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M116.725614_bib50","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nm1624","article-title":"Broad HIV-1 neutralization mediated by CD4-binding site antibodies","volume":"13","author":"Li","year":"2007","journal-title":"Nat. Med."},{"key":"10.1074\/jbc.M116.725614_bib51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"Walker","year":"2009","journal-title":"Science."},{"key":"10.1074\/jbc.M116.725614_bib52","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.cell.2015.11.056","article-title":"Immunogenicity of stabilized HIV-1 envelope trimers with reduced exposure of non-neutralizing epitopes","volume":"163","author":"de Taeye","year":"2015","journal-title":"Cell."},{"key":"10.1074\/jbc.M116.725614_bib53","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.chom.2014.07.003","article-title":"HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria","volume":"16","author":"Trama","year":"2014","journal-title":"Cell Host Microbe."},{"key":"10.1074\/jbc.M116.725614_bib55","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1128\/JVI.00426-12","article-title":"HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages","volume":"86","author":"Moody","year":"2012","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib56","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1128\/JVI.00562-08","article-title":"Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccination","volume":"82","author":"Vaine","year":"2008","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib57","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1128\/JVI.02827-12","article-title":"Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes","volume":"87","author":"Hoffenberg","year":"2013","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M116.725614_bib58","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.immuni.2012.11.011","article-title":"Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity."},{"key":"10.1074\/jbc.M116.725614_bib59","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ebiom.2015.06.016","article-title":"Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee","volume":"2","author":"Nicely","year":"2015","journal-title":"EBioMedicine."},{"key":"10.1074\/jbc.M116.725614_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10618","article-title":"Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice","volume":"7","author":"McGuire","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1074\/jbc.M116.725614_bib61","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/90444","article-title":"NMR structure of a parallel homotrimeric coiled coil","volume":"5","author":"Dames","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1074\/jbc.M116.725614_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.virol.2004.10.042","article-title":"Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage","volume":"332","author":"Pancera","year":"2005","journal-title":"Virology."},{"key":"10.1074\/jbc.M116.725614_bib63","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science."},{"key":"10.1074\/jbc.M116.725614_bib64","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.1207532","article-title":"Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing","volume":"333","author":"Wu","year":"2011","journal-title":"Science."},{"key":"10.1074\/jbc.M116.725614_bib65","doi-asserted-by":"crossref","first-page":"10339","DOI":"10.1021\/bi700577m","article-title":"Identification and thermodynamic characterization of molten globule states of periplasmic binding proteins","volume":"46","author":"Prajapati","year":"2007","journal-title":"Biochemistry."},{"key":"10.1074\/jbc.M116.725614_bib66","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1038\/nprot.2006.204","article-title":"Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions","volume":"1","author":"Greenfield","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1074\/jbc.M116.725614_bib67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","article-title":"EMAN2: an extensible image processing suite for electron microscopy","volume":"157","author":"Tang","year":"2007","journal-title":"J. Struct. Biol."},{"key":"10.1074\/jbc.M116.725614_bib68","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"Li","year":"2005","journal-title":"J. Virol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820317488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820317488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M116.725614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T04:36:57Z","timestamp":1641271017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820317488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0021925820317488"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m116.725614","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M116.725614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}